MedPath

Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis

Completed
Conditions
Infectious Keratitis
Interventions
Other: Sequencing
Drug: Treatment of bacterial keratitis
Drug: Treatment of fungal keratitis
Drug: Treatment of viral keratitis
Diagnostic Test: corneal scraping
Registration Number
NCT04213313
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

This study explores the association between single nucleotide polymorphism (Met11Thr) of surfactant protein D(SP-D) and susceptibility and prognosis of infectious keratitis.Met11Thr of SP-D of patients with keratitis and normal controls were compared.Allele and genotype frequencies of patients with keratitis and normal controls were determined by polymerase chain reaction with sequence specific primers(PCR-SSPs) .SP-D gene polymorphism of patients with keratitis and normal controls was detected by Sanger sequencing

Detailed Description

Surfactant protein D(SP-D) plays an important role in the innate immune system of the eye in the lacrimal duct, cornea and conjunctiva.The single lipopolysaccharide on the surface of bacteria and the receptors on the surface of immune cells are linked by SP-D ,which acts as a bridge to neutralize viruses in the innate immune defense system and assists other immune cells in clearing bacteria and fungi.SP-D can also participate in the acquired immune response after combining with lipopolysaccharide on the surface of microorganisms.Some single nucleotide polymorphisms of SP - D can not only affect the plasma level of SP - D, which leads to the differences of pathogen defense capability, but also can affect the space configuration and structure of carbohydrate recognition domain of SP-D, causing the change of ability of SP - D combined with pathogens to influence its defensive role.The concentration of SP - D in ocular surface is closely related to the occurrence and progression of infectious keratitis.Association between single nucleotide polymorphisms of SP-D and the occurrence and development of infectious keratitis has yet to be confirmed by research.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • Clinical diagnosis of Infectious Keratitis.
  • Laboratory diagnosis of Infectious Keratitis.
Exclusion Criteria
  • Patients with topical or systemic long-term use of hormones, interferon, or immunosuppressive therapy.
  • Patients with basic diseases such as diabetes, autoimmune disease, sjogren's syndrome, blepharitis, eyelid defect or incomplete eyelid closure.
  • Patients with history of corneal myopia laser, cataract surgery and vitrectomy, or history of serious ocular trauma and drug allergies.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control GroupSequencinghealth volunteers
Infectious Keratitis GroupTreatment of bacterial keratitisInfectious corneal patients
Infectious Keratitis GroupTreatment of fungal keratitisInfectious corneal patients
Infectious Keratitis GroupTreatment of viral keratitisInfectious corneal patients
Infectious Keratitis Groupcorneal scrapingInfectious corneal patients
Infectious Keratitis GroupSequencingInfectious corneal patients
Primary Outcome Measures
NameTimeMethod
Genotypebefore the treatment

Genotype of SNP(rs721917):( Met /Met , Thr/Thr and Met/Thr)

Base typebefore the treatment

Base type of SNP(rs721917):(Met and Thr)

Secondary Outcome Measures
NameTimeMethod
Grading of Keratitisbefore the treatment

Grading of Keratitis:

1. cornea:transparency ,edema,turbidity,perforation

2. conjunctiva: hyperaemia

3. blephar:inflammation

Trial Locations

Locations (1)

Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath